[email protected] +357 96 030922 Contact Us | FAQ |
Advanced search

Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Global Natural Sleep Aids Market by Product Type (Sleep Laboratories, Mattresses & Pillows, Medications (Herbal drugs), Sleep Apnea Devices (Facial Interfaces, Oral Appliances, Adaptive Servo-Ventilators (ASVs) and Others)), By Sleep Disorder(Insomnia, Narcolepsy, Sleep Walking, Sleep Apnea, Restless Legs Syndrome and Others), By Distribution Channel (Offline (Drug Stores , Retail Pharmacies and Hospital Pharmacies) and Online) and By Region (North America, Europe, Asia Pacific, South America, and Middle East & Africa)

 US$ 3,400.00

Global natural sleep aids market estimated to drive due to the growth in the number of sleep disorders and the rise in awareness about the adverse effects of sleep disorders on human health. The globa...

April 2021 215 pages

Global Regenerative Medicine Market by Technology (Cellular Therapy, Gene Therapy, Tissue Engineering, and Exosome Therapeutics), By Source (Autologous and Allogenic), By Application (Dermatology, Musculoskeletal, Oncology, Cardiovascular, Neurology, Hematology & Immunology, and Others), By End-Users (Hospitals, Ambulatory surgery centers (ASCs), Clinics and Others), and By Region (North America, Europe, Asia Pacific, South America, Middle East, and Africa)-Global forecast from 2020-2027

 US$ 3,400.00

Global Regenerative Medicine Market expected to thrust by the rise in diseases related to aging and growing chronic diseases. The global Regenerative Medicine Market likely to grow with CAGR 10.5% in...

April 2021 265 pages

Blockbuster Drugs Market, 2021-2030: Focus on Product Landscape Assessment, Ongoing Clinical Trials, Promotional Content Analysis, Other Life Cycle Management Strategies, Competition from Biosimilars, Annual Treatment Cost Comparison, Sales Evolution and Future Opportunity

 US$ 4,799.00

The blockbuster drugs market is expected to reach USD 75 billion in 2020 anticipated to grow at an exponential CAGR during the forecast period 2023-2035. The pursuit of more refined pharmacological tr...

April 2021 242 pages

Global C5 Complement Inhibitors Drug Market Opportunity, Drug Price, Sales & Clinical Trials Insight 2026

 US$ 2,400.00

Please note: extra shipping charges are applied when purchasing Hard Copy License depending on the location. ?Global C5 Complement Inhibitors Drug Market Opportunity, Drug Price, Sales & Clinical Tr...

April 2021 150 pages

Global CFTR Modulators Market Opportunity, Dosage, Price & Clinical Trials Insight 2026

 US$ 2,400.00

Please note: extra shipping charges are applied when purchasing Hard Copy License depending on the location. ?Global CFTR Modulators Market Opportunity, Dosage, Price & Clinical Trials Insight 2026?...

April 2021 150 pages

Gamma Delta T Cell Cancer Therapy Opportunity & Clinical Trials Insight 2026

 US$ 3,000.00

Please note: extra shipping charges are applied when purchasing Hard Copy License depending on the location. ?Gamma Delta T Cell Cancer Therapy Opportunity & Clinical Trials Insight 2026? Report Hig...

April 2021 180 pages

Global Covid-19 Vaccine Market – Analysis By Product Type, Patient Type, End User, By Region, By Country (2021 Edition): Market Insights, Competition and Forecast (2020-2030)

 US$ 2,000.00

EXECUTIVE SUMMARY Global Covid-19 vaccine Market will be valued at approximately USD 25 billion in the year 2024. The growing government support for vaccine development and the increasing involvement...

March 2021 214 pages

Acute Renal Failure (ARF) (Acute Kidney Injury) (Genitourinary Disorders) - Drugs in Development, 2021

 US$ 2,500.00

Acute Renal Failure (ARF) (Acute Kidney Injury) (Genitourinary Disorders) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute...

March 2021 242 pages

Acute Respiratory Distress Syndrome (Respiratory) - Drugs in Development, 2021

 US$ 2,500.00

Acute Respiratory Distress Syndrome (Respiratory) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Respiratory Distress Sy...

March 2021 836 pages

Alcohol Addiction (Central Nervous System) - Drugs in Development, 2021

 US$ 2,500.00

Alcohol Addiction (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Alcohol Addiction - Drugs in Develop...

March 2021 202 pages

Alopecia (Dermatology) - Drugs in Development, 2021

 US$ 2,500.00

Alopecia (Dermatology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Alopecia - Drugs in Development, 2021, provides an overv...

March 2021 249 pages

Amyloidosis (Metabolic Disorder) - Drugs in Development, 2021

 US$ 2,000.00

Amyloidosis (Metabolic Disorder) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Amyloidosis - Drugs in Development, 2021, prov...

March 2021 304 pages

Anthrax (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Anthrax (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anthrax - Drugs in Development, 2021, provides an...

March 2021 124 pages

Atypical Hemolytic Uremic Syndrome (Nondiarrhea - Associated Hemolytic Uremic Syndrome) (Gastrointestinal) - Drugs in Development, 2021

 US$ 2,000.00

Atypical Hemolytic Uremic Syndrome (Nondiarrhea - Associated Hemolytic Uremic Syndrome) (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Health...

March 2021 137 pages

Autism (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Autism (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Autism - Drugs in Development, 2021, provides a...

March 2021 175 pages

Bacterial Vaginosis (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Bacterial Vaginosis (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bacterial Vaginosis - Drugs in Develop...

March 2021 82 pages

Beta Nerve Growth Factor (Beta NGF or NGF) - Drugs in Development, 2021

 US$ 3,500.00

Beta Nerve Growth Factor (Beta NGF or NGF) - Drugs in Development, 2021 SUMMARY Beta Nerve Growth Factor (Beta NGF or NGF) pipeline Target constitutes close to 11 molecules. The latest report Beta Ner...

March 2021 63 pages

Birch Pollen Allergy (Immunology) - Drugs in Development, 2021

 US$ 2,000.00

Birch Pollen Allergy (Immunology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Birch Pollen Allergy - Drugs in Development,...

March 2021 47 pages

Botulism (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Botulism (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Botulism - Drugs in Development, 2021, provides a...

March 2021 38 pages

Cerebral Palsy (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Cerebral Palsy (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cerebral Palsy - Drugs in Development,...

March 2021 50 pages

Chemotherapy Induced Nausea and Vomiting (Other Diseases) - Drugs in Development, 2021

 US$ 2,000.00

Chemotherapy Induced Nausea and Vomiting (Other Diseases) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chemotherapy Induced...

March 2021 102 pages

Chemotherapy Induced Neutropenia (Other Diseases) - Drugs in Development, 2021

 US$ 2,000.00

Chemotherapy Induced Neutropenia (Other Diseases) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chemotherapy Induced Neutrope...

March 2021 158 pages

Cholera (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Cholera (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cholera - Drugs in Development, 2021, provides an...

March 2021 64 pages

Cluster Headache Syndrome (Cluster Headache) (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Cluster Headache Syndrome (Cluster Headache) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cluster H...

March 2021 92 pages

Cognitive Impairment Associated With Schizophrenia (CIAS) (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Cognitive Impairment Associated With Schizophrenia (CIAS) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline gu...

March 2021 90 pages

Colitis (Gastrointestinal) - Drugs in Development, 2021

 US$ 2,000.00

Colitis (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colitis - Drugs in Development, 2021, provides an ov...

March 2021 124 pages

Community Acquired Pneumonia (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Community Acquired Pneumonia (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Community Acquired Pneumonia...

March 2021 184 pages

Cyclin Dependent Kinase 4 (Cell Division Protein Kinase 4 or PSK J3 or CDK4 or EC 2.7.11.22) - Drugs in Development, 2021

 US$ 3,500.00

Cyclin Dependent Kinase 4 (Cell Division Protein Kinase 4 or PSK J3 or CDK4 or EC 2.7.11.22) - Drugs in Development, 2021 SUMMARY Cyclin Dependent Kinase 4 (Cell Division Protein Kinase 4 or PSK J3 or...

March 2021 223 pages

Degenerative Disc Disease (Musculoskeletal) - Drugs in Development, 2021

 US$ 2,000.00

Degenerative Disc Disease (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Degenerative Disc Disease - Drugs i...

March 2021 83 pages

Diabetic Macular Edema (Metabolic Disorder) - Drugs in Development, 2021

 US$ 2,500.00

Diabetic Macular Edema (Metabolic Disorder) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Macular Edema - Drugs in D...

March 2021 375 pages

Diabetic Peripheral Neuropathy (Metabolic Disorder) - Drugs in Development, 2021

 US$ 2,000.00

Diabetic Peripheral Neuropathy (Metabolic Disorder) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Peripheral Neuropa...

March 2021 87 pages

Diarrhea (Gastrointestinal) - Drugs in Development, 2021

 US$ 2,000.00

Diarrhea (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diarrhea - Drugs in Development, 2021, provides an...

March 2021 175 pages

Dilated Cardiomyopathy (Cardiovascular) - Drugs in Development, 2021

 US$ 2,000.00

Dilated Cardiomyopathy (Cardiovascular) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Dilated Cardiomyopathy - Drugs in Devel...

March 2021 71 pages

Down Syndrome (Genetic Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Down Syndrome (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Down Syndrome - Drugs in Development, 2021, p...

March 2021 100 pages

Elephantiasis (Lymphatic Filariasis) (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Elephantiasis (Lymphatic Filariasis) (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Elephantiasis - Drugs...

March 2021 30 pages

Erectile Dysfunction (Women's and Male Health) - Drugs in Development, 2021

 US$ 2,000.00

Erectile Dysfunction (Women's and Male Health) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Erectile Dysfunction - Drugs in...

March 2021 165 pages

Fatigue (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Fatigue (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fatigue - Drugs in Development, 2021, provides...

March 2021 37 pages

Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) - Drugs in Development, 2021

 US$ 3,500.00

Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) - Drugs in Development, 2021 SUMMARY Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) pipeline Target constitutes...

March 2021 183 pages

Fibromyalgia (Fibromyalgia Syndrome) (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Fibromyalgia (Fibromyalgia Syndrome) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fibromyalgia - Dr...

March 2021 145 pages

Functional (Non Ulcer) Dyspepsia (Gastrointestinal) - Drugs in Development, 2021

 US$ 2,000.00

Functional (Non Ulcer) Dyspepsia (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Functional (Non Ulcer) Dysp...

March 2021 45 pages

Hepatic Encephalopathy (Gastrointestinal) - Drugs in Development, 2021

 US$ 2,000.00

Hepatic Encephalopathy (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatic Encephalopathy - Drugs in Dev...

March 2021 101 pages

Hepcidin (Liver Expressed Antimicrobial Peptide 1 or Putative Liver Tumor Regressor or HAMP) - Drugs in Development, 2021

 US$ 3,500.00

Hepcidin (Liver Expressed Antimicrobial Peptide 1 or Putative Liver Tumor Regressor or HAMP) - Drugs in Development, 2021 SUMMARY According to the recently published report 'Hepcidin - Drugs in Develo...

March 2021 41 pages

Hidradenitis Suppurativa (Dermatology) - Drugs in Development, 2021

 US$ 2,000.00

Hidradenitis Suppurativa (Dermatology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hidradenitis Suppurativa - Drugs in Deve...

March 2021 279 pages

Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) - Drugs in Development, 2021

 US$ 3,500.00

Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) - Drugs in Development, 2021 SUMMARY Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) pipeline Target constit...

March 2021 71 pages

Histone Deacetylase 8 (Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98) - Drugs in Development, 2021

 US$ 3,500.00

Histone Deacetylase 8 (Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98) - Drugs in Development, 2021 SUMMARY Histone Deacetylase 8 (Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98) - Histone dea...

March 2021 32 pages

Hospital Acquired Pneumonia (HAP) (Infectious Disease) - Drugs in Development, 2021

 US$ 2,500.00

Hospital Acquired Pneumonia (HAP) (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hospital Acquired Pneumo...

March 2021 229 pages

House Dust Mite Allergy (Immunology) - Drugs in Development, 2021

 US$ 2,000.00

House Dust Mite Allergy (Immunology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide House Dust Mite Allergy - Drugs in Develop...

March 2021 63 pages

Human Papillomavirus Minor Capsid Protein L2 (L2) - Drugs in Development, 2021

 US$ 3,500.00

Human Papillomavirus Minor Capsid Protein L2 (L2) - Drugs in Development, 2021 SUMMARY Human Papillomavirus Minor Capsid Protein L2 (L2) - L2 is a minor capsid component and lacks the capacity to form...

March 2021 33 pages

Hyperalgesia (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Hyperalgesia (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hyperalgesia - Drugs in Development, 2021...

March 2021 38 pages

Hypoglycemia (Metabolic Disorder) - Drugs in Development, 2021

 US$ 2,000.00

Hypoglycemia (Metabolic Disorder) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hypoglycemia - Drugs in Development, 2021, pr...

March 2021 71 pages

Filters

Clear all

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1